Lenirit 0,5 % 20 g cream

Lenirit 0.5% 20 g cream is a dermatological cream based on hydrocortisone acetate , an active ingredient belonging to the class of corticosteroids, known for its anti-inflammatory and antipruritic action . This cortisone cream is indicated for the local treatment of insect bites , itching , erythema , circumscribed burns and eczema , offering rapid relief from the symptoms of skin inflammation and skin reactions of various origins.

Lenirit cream comes in a handy 20 g tube, ideal for topical use on limited skin areas. Its formulation, enriched with emollient and hydrating excipients, promotes the protection and restoration of the skin barrier , helping to reduce redness, swelling and discomfort. Thanks to the presence of 0.5% hydrocortisone acetate, Lenirit 0.5% is particularly effective in calming itching and soothing irritation caused by external agents or inflammatory dermatological conditions.

Lenirit anti-inflammatory cream is suitable for adults and can be used in all situations where a rapid and targeted intervention is needed against mild and moderate skin inflammation . The light and easily absorbed texture allows for comfortable application, without leaving greasy residues on the skin. Lenirit 0.5% 20 g cream represents a reliable solution for those looking for an effective treatment against itching, redness and skin irritation , ensuring rapid and localized action.

ACTIVE INGREDIENTS

Active ingredients contained in Lenirit 0.5% 20g cream - What is the active ingredient of Lenirit 0.5% 20g cream?

100 g of cream contain: Active ingredient : hydrocortisone acetate 0.5 g. Excipients with known effect : methyl parahydroxybenzoate; ethyl parahydroxybenzoate; propyl parahydroxybenzoate. For the full list of excipients, see section 6.1.

EXCIPIENTS

Composition of Lenirit 0.5% 20g cream - What does Lenirit 0.5% 20g cream contain?

Polyglycolic acid ester of C12-C18 fatty acids; self-emulsifying glyceryl monodistearate; squalane; cetyl palmitate; methyl parahydroxybenzoate; ethyl parahydroxybenzoate; propyl parahydroxybenzoate; perfume; purified water.

DIRECTIONS

Therapeutic indications Lenirit 0.5% 20 g cream - Why is Lenirit 0.5% 20 g cream used? What is it used for?

Insect bites, itching, localized rashes or burns, eczema.

CONTRAINDICATIONS AND SIDE EFFECTS

Contraindications Lenirit 0.5% 20 g cream - When should Lenirit 0.5% 20 g cream not be used?

Known hypersensitivity to the active substance or to any of the excipients listed in section 6.1. Infections and skin diseases: tuberculosis, pyoderma, mycosis, as well as skin ulcers and wounds, skin tumors. The use of the cream is contraindicated on the skin of the face, anogenital area, large lesions, infectious diseases (syphilis), viral infectious diseases (such as herpes, chickenpox), perioral dermatitis, acne, acne rosacea, skin reactions after vaccination, pustular psoriasis. Lenirit should not be used in infants and children under 2 years of age.

DOSAGE

Quantity and method of taking Lenirit 0.5% 20 g cream - How is Lenirit 0.5% 20 g cream taken?

Rub lightly and spread the cream thinly on the affected area, twice a day. Do not exceed the recommended doses. LENIRIT should not be used in children under two years of age (see section 4.3).

CONSERVATION

Storage Lenirit 0.5% 20 g cream - How is Lenirit 0.5% 20 g cream stored?

This medicinal product does not require any special storage conditions.

WARNINGS

Warnings Lenirit 0.5% 20 g cream - On Lenirit 0.5% 20 g cream it is important to know that:

If conditions worsen or if symptoms persist for more than 7 days, stop using and consult a doctor. Avoid contact with eyes. The use, especially if prolonged, of topical medications may give rise to irritation or sensitization phenomena. In this case, it is necessary to stop treatment and institute appropriate therapy. Prolonged use of this medicine may cause telangiectasia and skin atrophy. When used for a long time, or on a large area of ​​skin, hydrocortisone can be absorbed into the blood and exert a systemic activity. This is more likely to occur when occlusive dressing is used; the diaper can act as an occlusive dressing. Systemic absorption of topical corticosteroids may cause reversible suppression of the hypothalamic-pituitary-adrenal axis with potential glucocorticosteroid insufficiency after treatment discontinuation. Following systemic absorption of topical corticosteroids, manifestations of Cushing's syndrome, glycosuria, hyperglycemia may also occur in some patients during treatment. Patients applying a topical steroid over a large surface area or in areas under occlusive dressings should be monitored periodically for suppression of the hypothalamic-pituitary-adrenal axis. Visual disturbances: Visual disturbances may be reported with the use of systemic and topical corticosteroids. If a patient presents with symptoms such as blurred vision or other visual disturbances, consideration should be given to referring the patient to an ophthalmologist for evaluation of possible causes which may include cataract, glaucoma or rare diseases such as central serous chorioretinopathy (CSCR), which have been reported after use of systemic and topical corticosteroids. Appropriate precautions should be taken when used in the area adjacent to the eyes. If this occurs, the cream residue should be rinsed off with water. The cream contains ethyl parahydroxybenzoate, methyl parahydroxybenzoate and propyl parahydroxybenzoate which may cause allergic reactions (possibly delayed). Paediatric population : Do not use in neonates and children under 2 years of age (see section 4.3). Particular caution is recommended when using the medicinal product in children due to the risk of systemic exposure to hydrocortisone. Since the body surface area to body weight ratio in children is higher than in adults, children are at greater risk of systemic corticosteroid effects, including hypothalamic-pituitary-adrenal axis suppression and Cushing's syndrome, than adults. Prolonged use of corticosteroids in children may cause disturbances in growth and development. The duration of treatment should be as short as possible and the lowest dose should be used. The growth and development of the child should be monitored (see section 4.4). Use in elderly patients : Elderly people may experience more marked side effects, especially in cases of co-morbidities, such as osteoporosis, hypertension, hypokalaemia, diabetes mellitus, in addition to increased susceptibility to infections and reduced skin thickness. These people should be carefully monitored to avoid the occurrence of life-threatening reactions. In case of subcutaneous atrophic conditions, especially in the elderly, the medicine should be used with caution. Use in patients with renal or hepatic insufficiency : In patients with liver disease or renal insufficiency, special precautions for use should be used and frequent clinical monitoring of the state of health is necessary.

INTERACTIONS

Interactions Lenirit 0.5% 20 g cream - Which medicines or foods can modify the effect of Lenirit 0.5% 20 g cream?

No cases of interaction or incompatibility with other medicinal products have been reported.

SIDE EFFECTS

Like all medicines, Lenirit 0.5% 20g cream can cause side effects - What are the side effects of Lenirit 0.5% 20g cream?

The use, especially if prolonged, of products for topical use may give rise to irritation or sensitization phenomena. In this case it is necessary to interrupt the treatment and institute an appropriate therapy. During the application of the cream, acne, steroid-induced purpura, dry skin, hypertrichosis, hypopigmentation of the skin, skin atrophy and striae, telangiectasia, perioral dermatitis, folliculitis, pruritus, blurred vision may occur (see also paragraph 4.4). Increased absorption due to the use of an occlusive dressing may cause systemic effects such as oedema, hypertension and compromised immune system; suppression of the hypothalamic-pituitary-adrenal axis and Cushing's syndrome may also occur, particularly in paediatric patients. Prolonged use of corticosteroids in children may cause growth and development disorders (see paragraph 4.4). Glaucoma or cataract may occasionally occur following topical application to the eyelid area (see section 4.4). The incidence of adverse reactions is unknown. Reporting of suspected adverse reactions. Reporting suspected adverse reactions that occur after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.

OVERDOSE

Overdose Lenirit 0.5% 20g cream - What are the risks of Lenirit 0.5% 20g cream in case of overdose?

Cases of overdose are not known with the topical use of hydrocortisone at the concentration contained in LENIRIT (0.5%), however, avoid prolonged applications, especially on large surfaces. If high doses of the medicine are used on large areas of skin, under tight clothing or on damaged skin, the medicine can be absorbed into the blood and cause systemic corticosteroid effects (see section 4.4). In this case, a gradual withdrawal of the treatment is recommended.

PREGNANCY AND BREASTFEEDING

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Lenirit 0.5% 20 g cream.

The use of Lenirit is not recommended during pregnancy and breastfeeding.

DRIVING AND USE OF MACHINERY

Take Lenirit 0.5% 20g cream before driving or using machines - Does Lenirit 0.5% 20g cream affect driving or using machines?

This medicine does not affect the ability to drive or use machines.